Home ›
Data Desk › Decoy Therapeutics Inc. puts an S-3 shelf registration on file
MarginsX Data Desk · Offerings · Dilution · Equity line of credit · Name or ticker change · Reverse split
Decoy Therapeutics Inc. puts an S-3 shelf registration on file
On Nov 13, 2026, Decoy Therapeutics Inc. (DCOY) filed an S-3: a shelf registration for securities it can sell later. (SEC EDGAR, S-3, Nov 13, 2026)
By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 13, 2026.
Cash and dilution
It reported cash of $8.2M as of Sep 30, 2026. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)
At its recent quarterly burn rate that cash lasts about 10.6 months, by our estimate from its XBRL cash flows. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)
Its share count rose 388.3% over the past year. (Company health, computed by us from SEC filings and XBRL, Nov 11, 2026)
The stock
The Nasdaq screener puts its market value at $2.3M. (Nasdaq stock screener, Nov 13, 2026)
Follow it up
The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/DCOY)
The filing on SEC EDGAR. (sec.gov)
The filing in the MarginsX reader. (MarginsX reader)
Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.
Facts behind this article
| Fact | Value | Source | As of |
|---|
| Name | Decoy Therapeutics Inc. | Source | 2026-11-13 |
| Form | S-3 | Source | 2026-11-13 |
| Filed | Nov 13, 2026 | Source | 2026-11-13 |
| Who | Decoy Therapeutics Inc. (DCOY) | Source | 2026-11-13 |
| Symbol | DCOY | Source | 2026-11-13 |
| Cash | 8,168,071 USD | Source | 2026-09-30 |
| Cash date | Sep 30, 2026 | Source | 2026-09-30 |
| Runway | 10.6 months | Source | 2026-09-30 |
| Dilution 1y | 388.3 % | Source | 2026-11-11 |
| Cap | 2,326,127 USD | Source | 2026-11-13 |
Sources
Automated from SEC filings and market data. No AI. For information only. Not investment advice.
Discuss in MarginsX More from the Data Desk
More on MarginsX
Companies in this article
Topics
Related Data Desk stories
Every Data Desk article: /desk · RSS